三种连续版本商业化快速PCR检测筛查耐甲氧西林金黄色葡萄球菌的性能评估
该研究评估了XpertMRSA检测的三个连续版本(G3、Gen3和NxG)在常规MRSA筛查中的性能,并与培养法比较。结果显示灵敏度随时间改善但无统计学意义,而Gen3版本的特异度和阳性似然比显著低于其他版本(p < 0.00001)。结论强调评估商业化检测每个新版本性能的重要性。
要点
- 三个版本灵敏度分别为71.4%、82.3%和84.3%,改善无统计学意义。
- Gen3版本特异度和阳性似然比显著低于G3和NxG版本(p < 0.00001)。
- 商业化检测新版本上市前需重新评估性能。
核心结论
- XpertMRSA三个连续版本性能存在显著差异,Gen3版本特异度和阳性似然比显著较低,提示需评估每个新版本。
研究设计与样本
- 研究连续纳入常规MRSA筛查样本,同时进行培养和快速PCR检测,三个版本依次使用并与培养比较。
- G3、Gen3和NxG版本分别分析3512、2794和3288份样本。
主要发现
- 三个版本培养阳性率分别为5.0%、4.7%和4.3%。
- 灵敏度分别为71.4%(95%CI 64.0-77.9)、82.3%(95%CI 74.4-88.2)和84.3%(95%CI 77.0-89.7),改善无统计学意义。
- 特异度分别为98.4%(95%CI 97.9-98.8)、96.8%(95%CI 96.0-97.4)和99.1%(95%CI 98.7-99.4),Gen3显著较低(p < 0.00001)。
- 阳性似然比分别为45.7(95%CI 34.4-60.8)、25.6(95%CI 20.5-32.0)和97.1(95%CI 66.3-142.4),Gen3显著较低(p < 0.00001)。
临床怎么用
- 临床选用MRSA快速PCR筛查时,应关注具体版本性能差异,新版本使用前需验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Screening for methicillin-resistant Staphylococcus aureus (MRSA) is part of many recommendations to control MRSA. Several rapid PCR tests are available commercially and updated versions are constantly released. We aimed to evaluate the performance of three consecutive versions (G3, Gen3 and NxG) of the XpertMRSA test. METHODS: Routine samples for MRSA screening were simultaneously tested by culture and rapid PCR. The three versions of XpertMRSA were used successively and compared with culture. RESULTS: A total of 3512, 2794 and 3288 samples were analysed by culture and by the G3, Gen3 and NxG XpertMRSA versions, respectively. The rates of positive-by-culture in the three groups were 5.0%, 4.7% and 4.3%, respectively. The sensitivity improved over time (71.4, 95% CI 64.0-77.9; 82.3, 95% CI 74.4-88.2; and 84.3%, 95% CI 77.0-89.7, respectively), but not significantly. The specificity (98.4, 95% CI 97.9-98.8; 96.8, 95% CI 96.0-97.4; and 99.1, 95% CI 98.7-99.4, respectively) and the positive likelihood ratios (45.7, 95% CI 34.4-60.8; 25.6, 95% CI 20.5-32.0; and 97.1, 95% CI 66.3-142.4) were significantly lower in the Gen3 version (p < 0.00001). CONCLUSIONS: These significant differences in performance show the importance of evaluating each new version of a commercial test.
引用
- Bulliard E, Grandbastien B, Senn L, et al. Evaluation of three consecutive versions of a commercial rapid PCR test to screen for methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2019. PMID: 30980926. doi:10.1016/j.cmi.2019.03.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。